E
Sell
12/2/2024Upgraded
BioRegenx, Inc. (BRGX) was upgraded to E+ from E on 12/2/2024 due to an increase in the growth index, volatility index and valuation index. Operating cash flow increased 90.21% from -$318.6 to -$31.2, EBIT increased 68.52% from -$1.04M to -$327.3, and earnings per share increased from -$0.0012 to -$0.0004.
E
Sell
9/3/2024Upgraded
BioRegenx, Inc. (BRGX) was upgraded to E from E- on 9/3/2024 due to an increase in the total return index and valuation index.
E
Sell
6/5/2024None
BioRegenx, Inc. (BRGX) was downgraded to E- from U on 06/05/2024.
